Silvia de Muga

FGFR3 mutations in prostate cancer: association with low-grade tumors

Sílvia Hernández, Silvia de Muga, Laia Agell et al. · Modern Pathology · 2009 · 74 citations · Full text

Urology, Genitourinary Cancer, Molecular Oncology +4

Molecular alterations of EGFR and PTEN in prostate cancer: association with high-grade and advanced-stage carcinomas

Silvia de Muga, Sílvia Hernández, Laia Agell et al. · Modern Pathology · 2010 · 69 citations · Full text

Urology, Genitourinary Cancer, Medicine +8

A 12-Gene Expression Signature Is Associated with Aggressive Histological in Prostate Cancer

Laia Agell, Sílvia Hernández, Lara Nonell et al. · American Journal Of Pathology · 2012 · 67 citations · Full text

Aggressive Histological, Genitourinary Cancer, Medicine +11

Association of <i>ERG</i> and <i>TMPRSS2‐ERG</i> with grade, stage, and prognosis of prostate cancer is dependent on their expression levels

Alba Font‐Tello, Núria Juanpere, Silvia de Muga et al. · The Prostate · 2015 · 65 citations

Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer

Núria Juanpere, Laia Agell, Marta Lorenzo et al. · Human Pathology · 2012 · 62 citations

Urology, Urothelial Bladder Cancer, Genitourinary Cancer +5